Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
3(21%)
Results Posted
43%(3 trials)
Terminated
1(7%)

Phase Distribution

Ph phase_2
7
50%
Ph not_applicable
1
7%
Ph phase_1
3
21%

Phase Distribution

3

Early Stage

7

Mid Stage

0

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
3(27.3%)
Phase 2Efficacy & side effects
7(63.6%)
N/ANon-phased studies
1(9.1%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

77.8%

7 of 9 finished

Non-Completion Rate

22.2%

2 ended early

Currently Active

3

trials recruiting

Total Trials

14

all time

Status Distribution
Active(3)
Completed(7)
Terminated(2)
Other(2)

Detailed Status

Completed7
unknown2
Active, not recruiting2
Withdrawn1
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
3
Success Rate
87.5%
Most Advanced
Phase 2

Trials by Phase

Phase 13 (27.3%)
Phase 27 (63.6%)
N/A1 (9.1%)

Trials by Status

unknown214%
completed750%
withdrawn17%
active_not_recruiting214%
recruiting17%
terminated17%

Recent Activity

Clinical Trials (14)

Showing 14 of 14 trials
NCT03224000Phase 2

Trial of Magnetic Resonance Imaging Guided Radiotherapy Dose Adaptation in Human Papilloma Virus Positive Oropharyngeal Cancer

Active Not Recruiting
NCT02008656Phase 2

Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative Management

Active Not Recruiting
NCT04392622Phase 1

d-Limonene +Radiation +PlatinumBasedChemo for Xerostomia Prevention in LocallyAdvanced HNSCC

Recruiting
NCT02281955Phase 2

De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal SCC: Follow-up Study

Completed
NCT01530997Phase 2

De-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell Ca

Completed
NCT03077243Phase 2

P53 Mutational Status and cf HPV DNA for the Management of HPV-associated OPSCC

Completed
NCT03991104Phase 1

SOX-based CRT for Esophageal Cancer.

Withdrawn
NCT03342378

PET-MRI Assessment of Early Tumor Response to Predict Outcomes of HPV-Positive Oropharynx Cancer Patients

Completed
NCT03818100

Neo-RT: A Study Investigating Whether Changing the Sequence of Treatments (Starting Radiotherapy Followed by Hormone Therapy Before Surgery) is Feasible

Unknown
NCT04275986Phase 2

Concurrent Chemoradiotherapy After Endoscopic Resection for Stage I Esophageal Carcinoma

Unknown
NCT02520128Not Applicable

A Study of IMRT in Primary Bone and Soft Tissue Sarcoma

Completed
NCT02277184Phase 1

Ficlatuzumab, Cisplatin and IMRT in Locally Advanced Head and Neck Squamous Cell Carcinoma

Terminated
NCT00508703

Intensity Modulated Radiotherapy (IMRT) for the Pelvis Post-Hysterectomy

Completed
NCT01266512Phase 2

Concurrent Chemoradiotherapy Using Intensity Modulated Radiotherapy (IMRT) & Docetaxel-cisplatin (or Carboplatin) Followed by Adjuvant Chemotherapy for Inoperable Stage III Non-small-cell Lung Cancer

Completed

All 14 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
14